2Hellgren M,Olsson P,Thulin L.Effects of local thrombinemia andendotoxinemia on hepatic circulation in the anethetized dog[J].Scand J Clin Invest,2001,37(4):77.
3Bataller R,Brenner DA.Hepatic stellate cells as a target for the treatment of liver fibrosis[J].Semin Liver Dis,2001,21(2):437-451.
6Iacobellis A,Siciliano M,Perri F,et al.Peginterferon alfa-2b and ribavirin in patients with hepatitis C virus and decompensated cirrhosis:a controlled study[J].J Hepatol,2007,46(1):206-212.
3Blom IE, Goldschmeding R, Leask A. Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy? [J] Matrix Biol, 2002,21: 473-482.
4Miranda-Diaz A, Rincon AR, Salgado S, et al. Improved effects of viral gene delivery of human uPA plus biliodigestive anastomosis induce recovery from experimental biliary cirrhosis[J]. Mol Ther, 2004,9:30-37.
5Solis-Herruzo JA, de la Torre P, Munoz-Yague MT. Hepatic stellate cells (HSC): architects of hepatic fibrosis[J]. Rev Esp Enferm Dig, 2003, 95: 438-439.
6Safadi R, Friedman SL. Hepatic fibrosis-role of hepatic stellate cell activation[J]. Med Gen Med, 2002,4: 27-30.
7Friedman SL. Liver fibrosis-from bench to bedside[J]. J Hepatol,2003,8(supple1): S38-S53.
8David KS, Alan BW. Liver fibrosis and inflammation. A review[J]. Annals of Hepatol, 2003, 2: 159-163.
9Mehra A, Wrana JL.TGF-beta and the Smad signal transduction pathway[J]. Biochem Cell Biol, 2002,80(5): 605-622.
10Wells RG, Fibrogenesis V. TGF-beta signaling pathways[J]. Am J Physiol Gastrointest Liver Physiol, 2000, 279: G845-G850.
